| ¿µ¹® | hormone | ÇÑ±Û | È£¸£¸ó |
|---|---|---|---|
| ¼³¸í | È£¸£¸óÀ̶õ ƯÁ¤ÇÑ ³»ºÐºñ¼±¿¡¼ »ý¼º, ÀúÀåµÇ¾î ÀÖ´Ù°¡, °ü·ùÇÏ´Â Ç÷¾× ÁßÀ¸·Î ºÐºñµÈ ´ÙÀ½ Ç÷¾×¿¡ ½Ç·Á ¸Ö¸® ¶³¾îÁ® Àִ ǥÀû¼¼Æ÷(È£¸£¸óÀÌ ÀÛ¿ëÀ» ³ªÅ¸³»´Â ¼¼Æ÷)¿¡ À̸£·¯ ±×°÷¿¡¼ ƯÁ¤ÇÑ ±â´ÉÀ» ¹ßÈÖÇÏ´Â ¹°ÁúÀ» ¸»ÇÑ´Ù. ³»ºÐºñ»ùÀÌ ¾Æ´Ï´õ¶óµµ ¾î´À ¼¼Æ÷³ª ¼¼Æ÷±º¿¡¼ ¼¼Æ÷¿Ü¾× ÁßÀ¸·Î ºÐºñµÈ ´ÙÀ½ ´Ù¸¥ ¼¼Æ÷¿¡ °¡¼ ¼¼Æ÷ÀÇ ±â´ÉÀ» º¯µ¿½ÃŰ´Â ¹°ÁúÀÇ ÀϺεµ È£¸£¸óÀÇ ¹üÁÖ¿¡ Æ÷ÇÔ½Ã۰í ÀÖÀ¸¸ç À̵éÀ» Ưº°È÷ ±¹¼ÒÈ£¸£¸óÀ̶ó ºÎ¸¥´Ù(¿¹-¾Æ¼¼Æ¿Äݸ°, ¾Æµå·¹³¯¸°, ÄÝ·¹½Ã½ºÅäŰ´Ñ µî). ÀÌ¿¡ ºñÇØ¼ ƯÁ¤ ³»ºÐºñ»ù¿¡¼ Ç÷ÁßÀ¸·Î ºÐºñµÇ´Â ÁøÁ¤ÇÑ ÀǹÌÀÇ È£¸£¸óµéÀ» ÀϹÝÈ£¸£¸óÀ̶ó°í ºÎ¸¥´Ù. È£¸£¸óÀ» ÈçÈ÷ 3Á¾ÀÇ ¹«¸®·Î ºÐ·ù¸¦ Çϴµ¥ ¾Æµå·¹³¯¸°À̳ª thyroxine°ú °°ÀÌ ¾Æ¹Ì³ë»êÀÇ À¯µµÃ¼·Î µÈ È£¸£¸óµé(amine derivative), ¸¹Àº ¾Æ¹Ì³ë»êÀ» Àç·á·Î ¸¸µé¾îÁ³°Å³ª ´ç´Ü¹éÀ¸·Î µÈ ´Ü¹éÈ£¸£¸ó(peptide hormone), ±×¸®°í ÄÝ·¹½ºÅ×·ÑÀ» Àç·á·Î ¸¸µé¾îÁø Áö¹æÈ£¸£¸ó(steroid hormone) µîÀ¸·Î ±¸ºÐµÇ¸ç À̵éÀº ´ëü·Î Á¾·ù¿¡ µû¶ó ÀÛ¿ë¸ÞÄ¿´ÏÁòÀ» ´Þ¸®Çϰí ÀÖ´Ù. |
||
| ¿µ¹® | luteinizing hormone(LH) | ÇÑ±Û | ȲüÇü¼ºÈ£¸£¸ó |
|---|---|---|---|
| ¼³¸í | ¿©¼ºÀÇ ¿ù°æÀº Á¤ÇØÁø ¼ø¼¿¡ ÀÇÇØ ÀϾ°Ô µÈ´Ù. ¸ÕÀú ³Æ÷ÀÚ±ØÈ£¸£¸óÀÌ ³ú¿¡¼ ºÐºñµÇ¾î ¿©¼ºÀÇ ³¼Ò¸¦ ÀÚ±ØÇÏ°Ô µÇ¸é ³Æ÷°¡ ÀÚ±Ø¹Þ¾Æ ³Æ÷È£¸£¸ó(¿¡½ºÆ®·ÎÁ¨)À» ºÐºñÇÏ°Ô µÇ°í À̰ÍÀº ´Ù½Ã µÇ¸ÔÀ̱⠸ÞÄ¿´ÏÁò ÀÇÇØ ³ú¿¡ ÀÛ¿ëÀ» ÇÏ¿© ȲüÈÈ£¸£¸óÀÌ ³ú¿¡¼ ºÐºñµÇ°í À̰ÍÀÌ À̸¥¹Ù ÀýÁ¤¿¡ À̸£·¶À» ¶§, ³Æ÷¿¡¼ ¹è¶õÀÌ ÀϾ°Ô µÈ´Ù. ÀÌÈÄ ³Æ÷´Â Ȳü·Î º¯ÇÏ°Ô µÇ¸ç, ¹è¶õµÈ ³ÀÚ°¡ ¼öÁ¤µÇÁö ¾Æ´ÏÇϸé, Ȳü´Â Ȳüȣ¸£¸ó(ÇÁ·Î°Ô½ºÅ×·Ð)À» ºÐºñÇÑ µÚ ÅðÈµÇ°í °ð ÀÌ¾î ¿ù°æÀÌ ÀϾ°Ô µÈ´Ù. ÀÌ ÀÏÀº Á¤»óÀûÀÎ ´ëºÎºÐÀÇ ¿©¼º¿¡¼ 28ÀÏÀ» ÁÖ±â·Î ÀϾ¸ç, ´ë°³ ȲüÈÈ£¸£¸ó ÀýÁ¤ ÀÌÈÄ ¸¶Áö¸·Àº 14ÀÏ·Î ÀÏÁ¤ÇÏ´Ù°í ÇÑ´Ù. |
||
| HTS | head traumatic syndrome; HeLa tumor suppression; human thyroid-stimulating hormone, human thyroid st... |
|---|---|
| TSH-RF | thyroid-stimulating hormone-releasing factor |
| GHRFR | growth hormone-releasing releasing factor |
| FSH-RH | Follicle Stimulating Hormone Releasing Hormone |
| GHRH | Growth Hormone Releasing Hormone |
| hGHRH | Human growth-hormone-releasing hormone |
|---|---|
| LH-RH | Luteinising Hormone-Releasing Hormone |
| LRH | Luteinizing Hormone Releasing Hormone |
| LHRH-A | luteinizing hormone releasing hormone agonist |
| LHRHa | leuteinizing hormone-releasing hormone analogue |
| prolactin-releasing hormone | A polypeptide hormone that originates in the hypothalamus and stimulates the secretion of prolactin in the pituitary gland. (12 Dec 1998) |
|---|---|
| somatotropin-releasing hormone | <chemical> Hypothalamic peptide that regulates the synthesis and secretion of somatotropin in the anterior pituitary gland. Chemical name: Somatoliberin (12 Dec 1998) |
| thyrotrophic releasing hormone | <endocrinology> Tripeptide (pyroGlu His Pro NH2) that releases thyrotrophin from the anterior pituitary by stimulating adenyl cyclase. May also have neurotransmitter and paracrine functions. (18 Nov 1997) |
| thyrotropin-releasing hormone | <protein> See thyrotrophic releasing hormone. (18 Nov 1997) |
| thyrotropin-releasing hormone stimulation test | TRH stimulation test, a test of pituitary response to injection of thyrotropin-releasing hormone, which normally stimulates pituitary secretion of thyroid-stimulating hormone (TSH, thyrotropin), used primarily to distinguish pituitary from hypothalamic causes of thyroid disorders; TSH does not rise in cases of pituitary dysfunction, but does rise in cases of hypothalamic disorders. (05 Mar 2000) |
| follicle-stimulating hormone-releasing factor | A decapeptide of hypothalamic origin capable of accelerating pituitary secretion of follitropin. Synonym: follicle-stimulating hormone-releasing factor, follicle-stimulating hormone-releasing hormone. Origin: follicle-stimulating hormone + L. Libero, to free, + -in (05 Mar 2000) |
| luteinising hormone releasing factor | A decapeptide releasing hormone (1182D) that stimulates release of luteinising hormone. (18 Nov 1997) |
| luteinizing hormone-releasing factor | Former name for luteinizing hormone-releasing hormone. (05 Mar 2000) |
| receptors, thyroid hormone | Proteins, usually found in the nucleus, that specifically bind thyroid hormones and regulate DNA transcription. These proteins, termed c-erba, are activated by hormones and cause differentiation of erythroid progenitor cells which irreversibly lose proliferative potential. Thus c-erba proteins act as growth suppressors. The c-erba proteins are encoded by at least two genes, c-erba alpha and c-erba beta. Each of these has two isoforms. Mutations in the ligand-binding domain of the beta form causes thyroid hormone resistance syndrome. (12 Dec 1998) |
| hormone, thyroid | Chemical substance made by the thyroid gland which is located in the front of the neck. The thyroid gland uses iodine to make thyroid hormones. The two most important thyroid hormones are thyroxine (t4) and triiodothyronine (t3). (12 Dec 1998) |
| hormone, thyroid stimulating | A hormone produced by the pituitary gland (at the base of the brain) that promotes the growth of the thyroid gland (in the neck) and stimulates it to produce its thyroid hormones. Normally, the rate of thyroid hormone production is controlled by the pituitary. When there are insufficient thyroid hormones in the body for normal functioning of the cells, the pituitary releases tsh. Tsh in turn stimulates the thyroid gland to produce more thyroid hormones. In contrast, when there is excessive amount of thyroid hormones, the pituitary gland stops producing tsh. The tsh level then falls and thyroid hormone production is reduced. This mechanism maintains a relatively constant level of thyroid hormones circulating in the blood. This phenomenon is analogous to a thermostat used for temperature regulation in a room: when the temperature rises, the thermostat shuts the heater off and the room temperature falls back to normal. High levels of thyroid hormones cause the tsh level to fall, resulting in no further stimulation of the thyroid gland. In hyperthyroidism, there are continuously elevated levels of the thyroid hormones. Tsh is also known as thyrotropin. (12 Dec 1998) |
| thyroid hormone | <endocrinology> Thyroxine and tri iodothyronine are hormones secreted by the thyroid gland in vertebrates. These iodinated aromatic amino acid compounds influence growth and metabolism and, in amphibia, metamorphosis. The hormone calcitonin which has hypocalcaemic effects is also of thyroid origin but is not usually classed with thyroxine and tri iodothyronine as a thyroid hormone. (18 Nov 1997) |
| thyroid hormone aminotransferase | <enzyme> Chemical name: 3,5-dinitrotyrosine aminotransferase Registry number: EC 2.6.1.26 Synonym: triiodothyrone aminotransferase, triiodothyronine aminotransferase (26 Jun 1999) |
| thyroid hormone resistance syndrome | <syndrome> An inherited syndrome of peripheral resistance to thyroid hormones, transmitted as an autosomal recessive trait, characterised by increased serum concentrations of thyroxine and triiodothyronine, increased thyroid hormone binding ratio, and normal to slightly increased thyroid-stimulating hormone and its response to thyrotropin-releasing hormone. The affected persons are euthyroid to slightly hypothyroid. The absence of hypermetabolism and the presence of possible hypothyroidism indicate the existence of partial resistance to the peripheral action of thyroid hormone. (12 Dec 1998) |
| thyroid stimulating hormone | <endocrinology> Polypeptide hormone (28 kD), secreted by the anterior pituitary gland, that activates cyclic AMP production in thyroid cells leading to production and release of the thyroid hormones (T4 and T3). T4 and T3 blood levels feedback on the pituitary gland and decrease thyroid stimulating hormone production when T3 and T4 levels are high. (27 Sep 1997) |
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|
Á¦Ç°¸í |
ÆÇ¸Å»ç |
º¸ÇèÄÚµå | ¼ººÐ/ÇÔ·® | ±¸ºÐ/º¸Çè±Þ¿© |
|---|